Tech Company Financing Transactions
GliaCure Funding Round
On 8/5/2014, GliaCure received $5.8 million in Series B financing from private investors.
Transaction Overview
Company Name
Announced On
8/5/2014
Transaction Type
Venture Equity
Amount
$5,800,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
33 East Main St. 440
Madison, WI 53703
USA
Madison, WI 53703
USA
Phone
Website
Email Address
Overview
GliaCure is focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets.
Management Team
Browse more venture capital transactions:
Prev: 8/5/2014: Retention Science venture capital transaction
Next: 8/5/2014: SecureAuth venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs